Ophthalmic NSAIDS

Ophthalmic nonsteroidal anti-inflammatory drugs (NSAIDs) are a therapeutic class of topical ocular medications formulated as solutions or suspensions to manage localized pain and inflammatory conditions of the eye They exert their therapeutic effect primarily by inhibiting cyclooxygenase-1 and cyclooxygenase-2 (COX-1 and COX-2) enzymes, thereby blocking the synthesis of prostaglandins that drive ocular inflammation, vascular permeability, and pain sensitization

Ophthalmic nonsteroidal anti-inflammatory drugs (NSAIDs) are a therapeutic class of topical ocular medications formulated as solutions or suspensions to manage localized pain and inflammatory conditions of the eye They are also frequently used to prevent and manage postoperative cystoid macular edema

They exert their therapeutic effect primarily by inhibiting cyclooxygenase-1 and cyclooxygenase-2 (COX-1 and COX-2) enzymes, thereby blocking the synthesis of prostaglandins that drive ocular inflammation, vascular permeability, and pain sensitization

Clinically, they are most commonly utilized to prevent and treat postoperative inflammation and pain following cataract and refractive surgeries, maintain intraoperative pupillary dilation (preventing miosis), and reduce itching associated with seasonal allergic conjunctivitis

Clinically, they are most commonly utilized to prevent and treat postoperative inflammation and pain following cataract and refractive surgeries, maintain intraoperative pupillary dilation (preventing miosis), and reduce itching associated with seasonal allergic conjunctivitis

Clinically, they are most commonly utilized to prevent and treat postoperative inflammation and pain following cataract and refractive surgeries, maintain intraoperative pupillary dilation (preventing miosis), and reduce itching associated with seasonal allergic conjunctivitis

They are also frequently used to prevent and manage postoperative cystoid macular edema